⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL861365 | 0.75 | — | — | |
| SCHEMBL4857597 | 0.75 | — | — | |
| SCHEMBL15474318 | 0.72 | — | — | |
| Trichloroacetic Acid SCHEMBL1331955 | 0.67 | — | — | |
| SCHEMBL206379 | 0.67 | — | — | |
| Trichloroacetic Acid SCHEMBL10745837 | 0.67 | — | — | |
| SCHEMBL2746205 | 0.67 | — | — | |
| SCHEMBL20973 | 0.67 | — | — | |
| SCHEMBL6282434 | 0.67 | ALDH1A1 (0.54) | — | |
| Trichloroacetic Acid SCHEMBL10493657 | 0.67 | TSHR (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539029-B | Synthesis method of 5-fluoro salicylic acid | 浙江中欣氟材股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-114539029-A | Synthetic method of 5-fluorosalicylic acid | 浙江中欣氟材股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-8900830-B2 | Process for producing optically active succinimide derivatives | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2014-12-02 | — | — | US | claimed |
| US-20130196388-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE SUCCINIMIDE DERIVATIVES | KYOWA HAKKO BIO CO., LTD. (JP) | 2013-08-01 | — | — | US | claimed |
| EP-0923565-B1 | PROCESS FOR PREPARING PACLITAXEL | HANMI PHARMACEUTICAL CO LTD (KR) | 2001-11-07 | — | — | EP | claimed |
| CN-1072677-C | Method for synthesizing disaccharide and trisaccharide ortho-esters | ECOLOGICAL ENVIRONMENT RES CT (CN) | 2001-10-10 | — | — | CN | claimed |
| US-6130336-A | Process for preparing paclitaxel | HANMI PHARM., CO. LTD. (KR) | 2000-10-10 | — | — | US | claimed |
| CN-1242372-A | Method for synthesizing disaccharide and trisaccharide ortho-esters | ECOLOGICAL ENVIRONMENT RESEARC (CN) | 2000-01-26 | — | — | CN | claimed |
| EP-0923565-A1 | PROCESS FOR PREPARING PACLITAXEL | HANMI PHARMACEUTICAL CO.,LTD. (KR) | 1999-06-23 | — | — | EP | claimed |
| WO-1998008832-A1 | PROCESS FOR PREPARING PACLITAXEL | HANMI PHARM. CO., LTD. (KR) | 1998-03-05 | — | — | WO | claimed |
| CN-114539029-B | Synthesis method of 5-fluoro salicylic acid | 浙江中欣氟材股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-114539029-A | Synthetic method of 5-fluorosalicylic acid | 浙江中欣氟材股份有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-9434737-B2 | Process for producing optically active succinimide derivatives and intermediates thereof | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2016-09-06 | — | — | US | disclosed |
| US-8900830-B2 | Process for producing optically active succinimide derivatives | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20140099681-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE SUCCINIMIDE DERIVATIVES AND INTERMEDIATES THEREOF | KYOWA HAKKO BIO CO., LTD. (JP) | 2014-04-10 | — | — | US | disclosed |
| US-4180636-A | MAGNESIUM HALIDE, TITANIUM COMPOUND ELECTRON DONOR COMPOUND, TRIALKYL ALUMINUM CATALYST | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1979-12-25 | — | — | US | disclosed |
| US-4117036-A | ANAEROBIC CURABILITY, SEALANTS | BRIDGESTONE TIRE COMPANY LIMITED (JP) | 1978-09-26 | — | — | US | disclosed |
| US-4089815-A | Photopolymerization initiators | SUN CHEMICAL CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
| US-3992363-A | POLY(TRICHLOROACETYL-STYRENE) | SUN CHEMICAL CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3978133-A | UNSATURATED MONOMERS, POLYHALOACETYL | SUN CHEMICAL CORPORATION (US) | 1976-08-31 | — | — | US | disclosed |